Literature DB >> 28967902

A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.

C Chang1,2, J Liu1,2, W He1, M Qu3, X Huang1,2, Y Deng4, L Shen1,2, X Zhao4, H Guo4, J Jiang5, X Y Fu1, R Huang6, D Zhang7, J Yan1,2,8.   

Abstract

Heterochromatin protein 1γ (HP1γ) has been implicated in carcinogenesis of various cancer types. However, the role of HP1γ in prostate cancer (PCa) progression and the underlying molecular mechanisms remain largely unknown. We found that HP1γ is upregulated in PCa and elevated levels of HP1γ in PCa predict poor outcome. In addition, depletion of HP1γ in PCa cells not only repressed proliferation and induced apoptosis but also impaired tumorigenicity. We also found that c-Myc was capable of upregulating HP1γ by directly binding to the E-box element in the first intron of HP1γ gene, and the upregulated HP1γ, in turn, repressed the expression of miR-451a by enhancing H3K9 methylation at the promoter region of miR-451a. Furthermore, reduction of miR-451a significantly reversed HP1γ loss-induced PCa cell apoptosis, whereas miR-451a overexpression repressed cell survival by targeting and downregulating c-Myc. The association among c-Myc, HP1γ and miR-451a was further confirmed in human clinical samples. Therefore, we propose that an HP1γ/miR-451a/c-Myc regulatory circuitry exists in PCa cells and this circuit has a crucial role in PCa progression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28967902     DOI: 10.1038/onc.2017.332

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

1.  A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.

Authors:  Ming-Jer Huang; Yuan-chih Cheng; Chien-Ru Liu; Shufan Lin; H Eugene Liu
Journal:  Exp Hematol       Date:  2006-11       Impact factor: 3.084

2.  Synthesis of hybrid 4-deoxypodophyllotoxin-5-fluorouracil compounds that inhibit cellular migration and induce cell cycle arrest.

Authors:  Xiao-Wen Guan; Xiao-Hui Xu; Shi-Liang Feng; Zhen-Bo Tang; Shi-Wu Chen; Ling Hui
Journal:  Bioorg Med Chem Lett       Date:  2016-02-06       Impact factor: 2.823

Review 3.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers.

Authors:  Masakatsu Takanashi; Kosuke Oikawa; Koji Fujita; Motoshige Kudo; Masao Kinoshita; Masahiko Kuroda
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

6.  miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Authors:  Ismael Riquelme; Oscar Tapia; Pamela Leal; Alejandra Sandoval; Matthew G Varga; Pablo Letelier; Kurt Buchegger; Carolina Bizama; Jaime A Espinoza; Richard M Peek; Juan Carlos Araya; Juan Carlos Roa
Journal:  Cell Oncol (Dordr)       Date:  2015-10-12       Impact factor: 6.730

7.  Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring.

Authors:  Anthony E Rizzardi; Arthur T Johnson; Rachel Isaksson Vogel; Stefan E Pambuccian; Jonathan Henriksen; Amy Pn Skubitz; Gregory J Metzger; Stephen C Schmechel
Journal:  Diagn Pathol       Date:  2012-06-20       Impact factor: 2.644

Review 8.  miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.

Authors:  Emanuela Minna; Paola Romeo; Matteo Dugo; Loris De Cecco; Katia Todoerti; Silvana Pilotti; Federica Perrone; Ettore Seregni; Luca Agnelli; Antonino Neri; Angela Greco; Maria Grazia Borrello
Journal:  Oncotarget       Date:  2016-03-15

9.  Human p53 interacts with the elongating RNAPII complex and is required for the release of actinomycin D induced transcription blockage.

Authors:  Barbara N Borsos; Ildikó Huliák; Hajnalka Majoros; Zsuzsanna Ujfaludi; Ákos Gyenis; Peter Pukler; Imre M Boros; Tibor Pankotai
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

10.  Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy.

Authors:  Jae Duk Choi; Mi Ae Park; Jong-Soo Lee
Journal:  Nucleic Acids Res       Date:  2012-10-15       Impact factor: 16.971

View more
  22 in total

1.  Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.

Authors:  Jouhyun Jeon; Ekaterina Olkhov-Mitsel; Honglei Xie; Cindy Q Yao; Fang Zhao; Sahar Jahangiri; Carmelle Cuizon; Seville Scarcello; Renu Jeyapala; John D Watson; Michael Fraser; Jessica Ray; Kristina Commisso; Andrew Loblaw; Neil E Fleshner; Robert G Bristow; Michelle Downes; Danny Vesprini; Stanley Liu; Bharati Bapat; Paul C Boutros
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

2.  CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression.

Authors:  Pan Zhang; Xiaoyan Yang; Zhongming Zha; Yumeng Zhu; Guoqiang Zhang; Guotao Li
Journal:  Cell Cycle       Date:  2022-04-26       Impact factor: 5.173

3.  HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.

Authors:  Hunain Alam; Na Li; Shilpa S Dhar; Sarah J Wu; Jie Lv; Kaifu Chen; Elsa R Flores; Laura Baseler; Min Gyu Lee
Journal:  Cancer Res       Date:  2018-05-15       Impact factor: 12.701

Review 4.  Heterochromatin protein 1 (HP1): interactions with itself and chromatin components.

Authors:  Amarjeet Kumar; Hidetoshi Kono
Journal:  Biophys Rev       Date:  2020-03-06

5.  CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling.

Authors:  Zhengnan Huang; Yilin Yan; Zhen Zhu; Jiakuan Liu; Xiao He; Sumiya Dalangood; Meiqian Li; Mingyue Tan; Jinming Cai; Pengfei Tang; Ruimin Huang; Bing Shen; Jun Yan
Journal:  Cell Death Dis       Date:  2021-05-25       Impact factor: 8.469

6.  Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1γ isoform, lacking the chromoshadow domain.

Authors:  Angela Mathison; Thiago Milech De Assuncao; Nikita R Dsouza; Monique Williams; Michael T Zimmermann; Raul Urrutia; Gwen Lomberk
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

7.  Expression of miR-451a in Prostate Cancer and Its Effect on Prognosis.

Authors:  Bo Fan; Xiaohua Jin; Qi Ding; Cheng Cao; Yi Shi; Hailiang Zhu; Wenjun Zhou
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

8.  Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma.

Authors:  Di Cao; Xia Cao; Yu Jiang; Juan Xu; Yuhuan Zheng; Deying Kang; Caigang Xu
Journal:  Hematol Oncol       Date:  2021-12-17       Impact factor: 4.850

9.  Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer.

Authors:  Sumiya Dalangood; Zhen Zhu; Zhihui Ma; Jiaxuan Li; Qinghe Zeng; Yilin Yan; Bing Shen; Jun Yan; Ruimin Huang
Journal:  Theranostics       Date:  2020-08-08       Impact factor: 11.556

10.  CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.

Authors:  Xiaoping Zhong; Anna Kan; Wancong Zhang; Jianda Zhou; Huayong Zhang; Jiasheng Chen; Shijie Tang
Journal:  Aging (Albany NY)       Date:  2019-08-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.